http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2022, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 06 May 2020 16:01:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html for the full story. http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html Wed, 06 May 2020 16:01:00 -0400 4188 A.06822034 A.28474069 M3C MTLHY MTZPY NBIX http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html for the full story. http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html Wed, 06 May 2020 16:01:00 -0400 4188 A.06822034 A.28474069 M3C MTLHY MTZPY NBIX http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html for the full story. http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html Wed, 06 May 2020 16:01:00 -0400 4188 A.06822034 A.28474069 M3C MTLHY MTZPY NBIX http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html for the full story. http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html Wed, 06 May 2020 16:01:00 -0400 4188 A.06822034 A.28474069 M3C MTLHY MTZPY NBIX http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html for the full story. http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html Wed, 06 May 2020 16:01:00 -0400 4188 A.06822034 A.28474069 M3C MTLHY MTZPY NBIX http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html for the full story. http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html Wed, 06 May 2020 16:01:00 -0400 4188 A.06822034 A.28474069 M3C MTLHY MTZPY NBIX http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html for the full story. http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html Wed, 06 May 2020 16:01:00 -0400 4188 A.06822034 A.28474069 M3C MTLHY MTZPY NBIX http://www.streetinsider.com/PRNewswire/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html for the full story. http://www.streetinsider.com/PRNewswire/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html Wed, 06 May 2020 16:01:00 -0400 4188 A.06822034 A.28474069 M3C MTLHY MTZPY NBIX http://www.streetinsider.com/PRNewswire/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html for the full story. http://www.streetinsider.com/PRNewswire/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html Wed, 06 May 2020 16:01:00 -0400 4188 A.06822034 A.28474069 M3C MTLHY MTZPY NBIX http://www.streetinsider.com/PRNewswire/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html for the full story. http://www.streetinsider.com/PRNewswire/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html Wed, 06 May 2020 16:01:00 -0400 4188 A.06822034 A.28474069 M3C MTLHY MTZPY NBIX http://www.streetinsider.com/PRNewswire/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html for the full story. http://www.streetinsider.com/PRNewswire/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html Wed, 06 May 2020 16:01:00 -0400 4188 A.06822034 A.28474069 M3C MTLHY MTZPY NBIX http://www.streetinsider.com/PRNewswire/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html for the full story. http://www.streetinsider.com/PRNewswire/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html Wed, 06 May 2020 16:01:00 -0400 4188 A.06822034 A.28474069 M3C MTLHY MTZPY NBIX http://www.streetinsider.com/PRNewswire/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html for the full story. http://www.streetinsider.com/PRNewswire/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html Wed, 06 May 2020 16:01:00 -0400 4188 A.06822034 A.28474069 M3C MTLHY MTZPY NBIX http://www.streetinsider.com/PRNewswire/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html for the full story. http://www.streetinsider.com/PRNewswire/Neurocrine+Biosciences+Reports+First+Quarter+2020+Financial+Results/16843160.html Wed, 06 May 2020 16:01:00 -0400 4188 A.06822034 A.28474069 M3C MTLHY MTZPY NBIX http://www.streetinsider.com/Press+Releases/Mitsubishi+Tanabe+Pharma+America+Marks+Third+Anniversary+Of+FDA+Approval+And+Reports+More+Than+5%2C000+Patients+With+ALS+Treated+With+RADICAVA%C2%AE+%28edaravone%29/16833556.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Mitsubishi+Tanabe+Pharma+America+Marks+Third+Anniversary+Of+FDA+Approval+And+Reports+More+Than+5%2C000+Patients+With+ALS+Treated+With+RADICAVA%C2%AE+%28edaravone%29/16833556.html for the full story. http://www.streetinsider.com/Press+Releases/Mitsubishi+Tanabe+Pharma+America+Marks+Third+Anniversary+Of+FDA+Approval+And+Reports+More+Than+5%2C000+Patients+With+ALS+Treated+With+RADICAVA%C2%AE+%28edaravone%29/16833556.html Tue, 05 May 2020 09:14:00 -0400 4188 A.06822034 A.14320728 A.16133881 M3C MTLHY MTZPY http://www.streetinsider.com/Press+Releases/Mitsubishi+Tanabe+Pharma+America+Marks+Third+Anniversary+Of+FDA+Approval+And+Reports+More+Than+5%2C000+Patients+With+ALS+Treated+With+RADICAVA%C2%AE+%28edaravone%29/16833556.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Mitsubishi+Tanabe+Pharma+America+Marks+Third+Anniversary+Of+FDA+Approval+And+Reports+More+Than+5%2C000+Patients+With+ALS+Treated+With+RADICAVA%C2%AE+%28edaravone%29/16833556.html for the full story. http://www.streetinsider.com/Press+Releases/Mitsubishi+Tanabe+Pharma+America+Marks+Third+Anniversary+Of+FDA+Approval+And+Reports+More+Than+5%2C000+Patients+With+ALS+Treated+With+RADICAVA%C2%AE+%28edaravone%29/16833556.html Tue, 05 May 2020 09:14:00 -0400 4188 A.06822034 A.14320728 A.16133881 M3C MTLHY MTZPY http://www.streetinsider.com/Press+Releases/Mitsubishi+Tanabe+Pharma+America+Marks+Third+Anniversary+Of+FDA+Approval+And+Reports+More+Than+5%2C000+Patients+With+ALS+Treated+With+RADICAVA%C2%AE+%28edaravone%29/16833556.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Mitsubishi+Tanabe+Pharma+America+Marks+Third+Anniversary+Of+FDA+Approval+And+Reports+More+Than+5%2C000+Patients+With+ALS+Treated+With+RADICAVA%C2%AE+%28edaravone%29/16833556.html for the full story. http://www.streetinsider.com/Press+Releases/Mitsubishi+Tanabe+Pharma+America+Marks+Third+Anniversary+Of+FDA+Approval+And+Reports+More+Than+5%2C000+Patients+With+ALS+Treated+With+RADICAVA%C2%AE+%28edaravone%29/16833556.html Tue, 05 May 2020 09:14:00 -0400 4188 A.06822034 A.14320728 A.16133881 M3C MTLHY MTZPY http://www.streetinsider.com/Press+Releases/Mitsubishi+Tanabe+Pharma+America+Marks+Third+Anniversary+Of+FDA+Approval+And+Reports+More+Than+5%2C000+Patients+With+ALS+Treated+With+RADICAVA%C2%AE+%28edaravone%29/16833556.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Mitsubishi+Tanabe+Pharma+America+Marks+Third+Anniversary+Of+FDA+Approval+And+Reports+More+Than+5%2C000+Patients+With+ALS+Treated+With+RADICAVA%C2%AE+%28edaravone%29/16833556.html for the full story. http://www.streetinsider.com/Press+Releases/Mitsubishi+Tanabe+Pharma+America+Marks+Third+Anniversary+Of+FDA+Approval+And+Reports+More+Than+5%2C000+Patients+With+ALS+Treated+With+RADICAVA%C2%AE+%28edaravone%29/16833556.html Tue, 05 May 2020 09:14:00 -0400 4188 A.06822034 A.14320728 A.16133881 M3C MTLHY MTZPY http://www.streetinsider.com/Press+Releases/Mitsubishi+Tanabe+Pharma+America+Marks+Third+Anniversary+Of+FDA+Approval+And+Reports+More+Than+5%2C000+Patients+With+ALS+Treated+With+RADICAVA%C2%AE+%28edaravone%29/16833556.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Mitsubishi+Tanabe+Pharma+America+Marks+Third+Anniversary+Of+FDA+Approval+And+Reports+More+Than+5%2C000+Patients+With+ALS+Treated+With+RADICAVA%C2%AE+%28edaravone%29/16833556.html for the full story. http://www.streetinsider.com/Press+Releases/Mitsubishi+Tanabe+Pharma+America+Marks+Third+Anniversary+Of+FDA+Approval+And+Reports+More+Than+5%2C000+Patients+With+ALS+Treated+With+RADICAVA%C2%AE+%28edaravone%29/16833556.html Tue, 05 May 2020 09:14:00 -0400 4188 A.06822034 A.14320728 A.16133881 M3C MTLHY MTZPY http://www.streetinsider.com/Press+Releases/Mitsubishi+Tanabe+Pharma+America+Marks+Third+Anniversary+Of+FDA+Approval+And+Reports+More+Than+5%2C000+Patients+With+ALS+Treated+With+RADICAVA%C2%AE+%28edaravone%29/16833556.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Mitsubishi+Tanabe+Pharma+America+Marks+Third+Anniversary+Of+FDA+Approval+And+Reports+More+Than+5%2C000+Patients+With+ALS+Treated+With+RADICAVA%C2%AE+%28edaravone%29/16833556.html for the full story. http://www.streetinsider.com/Press+Releases/Mitsubishi+Tanabe+Pharma+America+Marks+Third+Anniversary+Of+FDA+Approval+And+Reports+More+Than+5%2C000+Patients+With+ALS+Treated+With+RADICAVA%C2%AE+%28edaravone%29/16833556.html Tue, 05 May 2020 09:14:00 -0400 4188 A.06822034 A.14320728 A.16133881 M3C MTLHY MTZPY http://www.streetinsider.com/Press+Releases/Mitsubishi+Tanabe+Pharma+America+Marks+Third+Anniversary+Of+FDA+Approval+And+Reports+More+Than+5%2C000+Patients+With+ALS+Treated+With+RADICAVA%C2%AE+%28edaravone%29/16833556.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Mitsubishi+Tanabe+Pharma+America+Marks+Third+Anniversary+Of+FDA+Approval+And+Reports+More+Than+5%2C000+Patients+With+ALS+Treated+With+RADICAVA%C2%AE+%28edaravone%29/16833556.html for the full story. http://www.streetinsider.com/Press+Releases/Mitsubishi+Tanabe+Pharma+America+Marks+Third+Anniversary+Of+FDA+Approval+And+Reports+More+Than+5%2C000+Patients+With+ALS+Treated+With+RADICAVA%C2%AE+%28edaravone%29/16833556.html Tue, 05 May 2020 09:14:00 -0400 4188 A.06822034 A.14320728 A.16133881 M3C MTLHY MTZPY http://www.streetinsider.com/PRNewswire/Mitsubishi+Tanabe+Pharma+America+Marks+Third+Anniversary+Of+FDA+Approval+And+Reports+More+Than+5%2C000+Patients+With+ALS+Treated+With+RADICAVA%C2%AE+%28edaravone%29/16833556.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Mitsubishi+Tanabe+Pharma+America+Marks+Third+Anniversary+Of+FDA+Approval+And+Reports+More+Than+5%2C000+Patients+With+ALS+Treated+With+RADICAVA%C2%AE+%28edaravone%29/16833556.html for the full story. http://www.streetinsider.com/PRNewswire/Mitsubishi+Tanabe+Pharma+America+Marks+Third+Anniversary+Of+FDA+Approval+And+Reports+More+Than+5%2C000+Patients+With+ALS+Treated+With+RADICAVA%C2%AE+%28edaravone%29/16833556.html Tue, 05 May 2020 09:14:00 -0400 4188 A.06822034 A.14320728 A.16133881 M3C MTLHY MTZPY http://www.streetinsider.com/PRNewswire/Mitsubishi+Tanabe+Pharma+America+Marks+Third+Anniversary+Of+FDA+Approval+And+Reports+More+Than+5%2C000+Patients+With+ALS+Treated+With+RADICAVA%C2%AE+%28edaravone%29/16833556.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Mitsubishi+Tanabe+Pharma+America+Marks+Third+Anniversary+Of+FDA+Approval+And+Reports+More+Than+5%2C000+Patients+With+ALS+Treated+With+RADICAVA%C2%AE+%28edaravone%29/16833556.html for the full story. http://www.streetinsider.com/PRNewswire/Mitsubishi+Tanabe+Pharma+America+Marks+Third+Anniversary+Of+FDA+Approval+And+Reports+More+Than+5%2C000+Patients+With+ALS+Treated+With+RADICAVA%C2%AE+%28edaravone%29/16833556.html Tue, 05 May 2020 09:14:00 -0400 4188 A.06822034 A.14320728 A.16133881 M3C MTLHY MTZPY http://www.streetinsider.com/PRNewswire/Mitsubishi+Tanabe+Pharma+America+Marks+Third+Anniversary+Of+FDA+Approval+And+Reports+More+Than+5%2C000+Patients+With+ALS+Treated+With+RADICAVA%C2%AE+%28edaravone%29/16833556.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Mitsubishi+Tanabe+Pharma+America+Marks+Third+Anniversary+Of+FDA+Approval+And+Reports+More+Than+5%2C000+Patients+With+ALS+Treated+With+RADICAVA%C2%AE+%28edaravone%29/16833556.html for the full story. http://www.streetinsider.com/PRNewswire/Mitsubishi+Tanabe+Pharma+America+Marks+Third+Anniversary+Of+FDA+Approval+And+Reports+More+Than+5%2C000+Patients+With+ALS+Treated+With+RADICAVA%C2%AE+%28edaravone%29/16833556.html Tue, 05 May 2020 09:14:00 -0400 4188 A.06822034 A.14320728 A.16133881 M3C MTLHY MTZPY http://www.streetinsider.com/PRNewswire/Mitsubishi+Tanabe+Pharma+America+Marks+Third+Anniversary+Of+FDA+Approval+And+Reports+More+Than+5%2C000+Patients+With+ALS+Treated+With+RADICAVA%C2%AE+%28edaravone%29/16833556.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Mitsubishi+Tanabe+Pharma+America+Marks+Third+Anniversary+Of+FDA+Approval+And+Reports+More+Than+5%2C000+Patients+With+ALS+Treated+With+RADICAVA%C2%AE+%28edaravone%29/16833556.html for the full story. http://www.streetinsider.com/PRNewswire/Mitsubishi+Tanabe+Pharma+America+Marks+Third+Anniversary+Of+FDA+Approval+And+Reports+More+Than+5%2C000+Patients+With+ALS+Treated+With+RADICAVA%C2%AE+%28edaravone%29/16833556.html Tue, 05 May 2020 09:14:00 -0400 4188 A.06822034 A.14320728 A.16133881 M3C MTLHY MTZPY